Gliknik Competitors and Similar CompaniesClear all
Gliknik's competitors and similar companies include Metys Pharmaceuticals, Scopus BioPharma, Kernal Biologics and Mersana Therapeutics.
 Gliknik Gliknik is a biopharmaceutical company creating therapies for people living with cancer and immune disorders. |  Metys Pharmaceuticals Metys Pharmaceuticals is a company that provides treatment for chemotherapy-induced peripheral neuropathy, a side effect of several cancer treatments. |  Scopus BioPharma Scopus BioPharma (formerly known as Project18) is a biopharmaceutical company developing therapeutics targeting diseases with unmet medical needs. |  Mersana Therapeutics Mersana Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugate (ADC) platforms. | ||
Founding Date | Founding Date 2007 | Founding Date 2013 | Founding Date 2017 | Founding Date 2016 | Founding Date 2005 |
Type | Type Private | Type Private | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Baltimore, US HQ | Locations Basel, CH HQ Basel, CH | Locations New York, US HQ | Locations Cambridge, US HQ | Locations Cambridge, US HQ |
Employees | Employees 9 | Employees 2 | Employees 1344% increase | Employees 15 | Employees 11033% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 21 k | Valuation ($) N/A | Valuation ($) 250.3 m |
Financial | |||||
Net income | Net income N/A | Net income N/A | Net income ($11.7m) (FY, 2022) | Net income N/A | Net income ($69.2m) (FY, 2024) |
Funding | |||||
Latest funding round | Latest funding round $ 11.5m (almost 5 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 25m (almost 4 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 65.1m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 25.5m | Total funding raised $ 219.5m |
For sources of this data, please see the company profile
View Company Profiles
Metys Pharmaceuticals
HQ
Basel, CH
Employees
2
Metys Pharmaceuticals is a company that provides treatment for chemotherapy-induced peripheral neuropathy, a side effect of several cancer treatments.
View companyScopus BioPharma
HQ
New York, US
Employees
13↑ 44% increase
Scopus BioPharma (formerly known as Project18) is a biopharmaceutical company developing therapeutics targeting diseases with unmet medical needs.
View company
Kernal Biologics
HQ
Cambridge, US
Employees
15
Kernal Biologics is a biotech company that creates mRNA therapies.
View companyMersana Therapeutics
HQ
Cambridge, US
Employees
110↑ 33% increase
Mersana Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugate (ADC) platforms.
View company